NCT06302049View on ClinicalTrials.gov

Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2026

Conditions
Fatty Liver DiseaseSteatohepatitis, Nonalcoholic
Interventions
DRUG

Esomeprazole

esomeprazole 20 mg once daily

DRUG

Placebo

Placebo once daily

Trial Locations (1)

Unknown

RECRUITING

National Liver Institute, Shibīn al Kawm

All Listed Sponsors
lead

Sadat City University

OTHER